Editorial Information

Trinseo Introduces Biocompatible Polystyrene for Medical Devices

ISO 10993-Compliant for Packaging, Devices & Housings

HORGEN, Switzerland - Monday, June 20, 2016
(NYSE: TSE), the global materials company and manufacturer of plastics, latex binders and synthetic rubber, is introducing a general purpose polystyrene (GPPS) specifically for the medical devices market. STYRON™ 2678 MED Polystyrene Resin offers the versatility of polystyrene with the added assurance for the medical market of ISO 10993 compliance and an extended notification of change.

STYRON™ 2678 MED Polystyrene Resins can be used for a variety of medical device applications including clear packaging, diagnostic components, petri dishes and housings for test kits.

Highlights of the resin material include excellent transparency (approx. 90% transmission), stiffness, rigidity and heat resistance.  Properties supporting medical device applications include biocompatibility, sterilization stability, and chemical resistance to fight infection. The material may also be processed further with secondary operations such as solvent bonding, welding and laser marking, typical for medical devices. 

“There’s a growing need - especially within medical packaging – for a medical grade polymer that performs well, protects the product, and provides an added degree of safety,” said Ben Porter, technical service & development engineer, Trinseo, Netherlands.  “STYRON™ 2678 MED Polystyrene Resin provides customers with an ideal and economical solution and an alternative to general purpose food grade polystyrene.”

Trinseo has served the global medical devices market with high performance plastics for single- and multiple-use devices and equipment housings for nearly three decades.  The company offers worldwide production and fulfillment, recently announcing its medical compounding capability in Asia Pacific to complement existing compounding in Europe and North America.

STYRON™ 2678 MED Polystyrene Resin expands Trinseo’s offering of transparent materials for medical applications. 

About Trinseo

Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.0 billion in net sales in 2020, with 17 manufacturing sites around the world, and approximately 2,600 employees. For more information, please visit: www.trinseo.com.

Cautionary Note on Forward-Looking Statements

This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding the timing of the proposed acquisition of the Arkema MMA and PMMA business (the "Acquisition"); estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities and cost synergies relating to the Acquisition, our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause such a difference include, but are not limited to, our failure to complete the Acquisition or meet the conditions to closing, including antitrust, works council and other regulatory approvals; the failure to obtain the financing necessary to fund the Acquisition and the impact of the substantial indebtedness to be incurred; costs related to the Acquisition; following the Acquisition, our ability to successfully integrate the acquired businesses, generate expected cost savings and synergies, maintain relationships with customers, retain key employees and profitably grow the business; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Editorial Information

Trinseo News

November 3 - November 4, 2021 Architects @ Work Location - Milan, Italy Business alignment - Engineered Materials

Get Exclusive Trinseo Content

Be the first to hear about new product information, company news, and more Trinseo updates conveniently via email!